Table 2.
Procedural data and events.
| CANO (N = 92) | Conventional stenosis (N = 106) | P value | CANO with full collapse (N = 45) | CANO without full collapse (N = 47) | P value¶ | |
|---|---|---|---|---|---|---|
| Pre-dilatation before EPD | 8 (9%) | 2 (2%) | 0.029 | 8 (18%) | 0 (0%) | 0.002 |
| EPD usage | 90 (98%) | 106 (100%) | 0.127 | 43 (96%) | 47 (100%) | 0.144 |
| Pre-dilatation before stent deployment | 28 (30%) | 12 (11%) | 0.001 | 17 (38%) | 11 (23%) | 0.134 |
| Stent across carotid bifurcation | 80 (87%) | 92 (87%) | 0.973 | 39 (87%) | 41 (87%) | 0.936 |
| Post-dilatation | 89 (97%) | 96 (91%) | 0.080 | 43 (96%) | 46 (98%) | 0.532 |
| Bradycardia* | 13 (14%) | 12 (11%) | 0.553 | 5 (11%) | 8 (17%) | 0.416 |
| Hypotension* | 27 (29%) | 20 (19%) | 0.084 | 16 (36%) | 11 (23%) | 0.201 |
| TIA | 3 (3%) | 2 (2%) | 0.665 | 2 (4%) | 1 (2%) | 0.613 |
EPD: distal Embolic protection device; TIA: transient ischemic attack.
*Bradycardia and hypotension defined by the needs of chronotropic/vasoactive agents use after stenting.
¶P value of comparing CANO patients with and without full collapse.